Forty-three patients with juvenile myoclonic epilepsy (JME) is presented. The female to male ratio was 2.9: 1. The patients answered a standardized questionnaire pertaining to social situation, medical history, onset of epilepsy, types and frequency of seizures, treatment, experienced control over seizures and consequences of having epilepsy. Myoclonic jerks, which are the hallmark of the condition, are often forgotten by the patients or not considered as epileptic seizures. This could be one reason why JME still seems underdiagnosed. JME may comprise absence, myoclonic and generalized tonic-clonic seizures (GTCS), proposed to occur in age-related sequence. We found that absence seizures may start after onset of other seizures. Our results confirm the need for medication since, during the last year, only 7% were seizure free without medication. Of patients on antiepileptic drugs (AEDs), 79.5% had no GTCS and 41% were seizure free during the last year, which confirms a relatively good response to appropriate treatment. Although most patients used AED daily and many still had one or more types of epileptic seizure, the epilepsy in general had very little impact on their lives.
INTRODUCTION
Juvenile myoclonic epilepsy (JME) is an idiopathic generalized epilepsy. The mean onset is around 15 years of age, but may vary between 8 and 26 yearslm3. Juvenile myoclonic epilepsy is characterized by myoclonic jerks (myoclonic seizures: MS), predominantly in the arms. Myoclonic seizures occur mostly after awakening. Many patients also have generalized tonic-clonic seizures (GTCS), and some have absence seizures (AS). The different seizure types may occur in an age-related sequence. Interictal and ictal EEG is characterized by rapid generalized spike waves and polyspike waves. Patients respond well to appropriate antiepileptic drugs (AED) therapy, and sodium valproate (VPA) is the drug of choice. Teratogenicity is a topic of special importance, however, since many young women are affected.
Juvenile myoclonic epilepsy still seems underdiagnosed, although the syndrome is well characterized, and accounts for 5-l 1% of the adult epileptic population'.
Diagnosis is often delayed due to insufficient knowledge of the syndrome2,4-6. Variation in prevalence may reflect variation in diagnostic criteria, or undiagnosed patients. The development of seizure types and long-term prognosis in patients are uncertain, and consequently the indication for discontinuation of medication.
There is general agreement that the disease is genetically determined. Different modes of inheritance have been proposed. Reports7-' ' indicate linkage to the HLA-region of chromosome 6p of a locus predisposing to JME. Subsequent studies do not confirm this and propose genetic heterogeneity or compound influence of the EJM-1 and other genes12-".
Linkage to the HLA region and genetic heterogeneity makes it important to study JME in different populations. The possibility of enhanced heterogeneity in epilepsy populations with great variation in onset prompted us to characterize a homogeneous group of JME patients with respect to seizures, medication, psychosocial aspects and prognosis.
PATIENTS AND METHODS

Patients
Medical records of 65 epilepsy patients registered with possible JME and attending the Neurological Department at Haukeland University Hospital were studied. Since no established dejinition of JME exists, despite clinical description", we used the following diagnostic criteria for this study. Certain JME: myoclonic jerks, f GTC or absences; onset 15 f4 years; EEG: bilateral polyspike waves. Probable JME: myoclonic jerks, +GTK or absences; onset 15 f 7 years; EEG: bilateral epileptic activity. Common criteria: no evidence of head trauma, encephalitis or degenerative disease as a causative factor, no evidence of mental retardation; slight or infrequent EEG asymmetries were not considered as exclusion criteria16T 17.
The diagnosis of JME was judged to be certain or probable in 49 cases. All were asked to participate, but four did not show up. Forty-five patients were interviewed, and the questionnaire was returned by 43.
The questionnaire
The patients were asked to answer a standardized questionnaire about the following subjects: social situation; family and own medical history; onset of epilepsy; types and frequency of seizures; provocational factors and treatment. The patients were, for instance, asked to confirm or deny the presence of a seizure type. In addition, the patients were asked about feeling of control over seizures and consequences of having epilepsy. These latter questions had graded answers, i.e. the patients were asked to mark one of seven boxes describing the answers from, for instance, 'Not at all' (score: 1) to 'High degree' (score: 7).
RESULTS
Patients
Forty-three patients returned the questionnaire (96%), 32 women and 11 men. Of these 21 patients had certain and 22 probable JME. In the group of probable JME we included a male patient with anamnestic myoclonic status epilepticus with loss of consciousness and interictal bilateral epileptic activity in EEG, in spite of no observed polyspikes. Duration of treatment varied from l-39 years. The mean age of the patients was 29 f 9 (SD) years (range 17-57 years). Twenty-one were single, twelve married, eight living with steady partners and two divorced. Sixteen patients had children. Fifteen patients had higher education and eleven were students. Twenty-four were employed, one was unemployed, three had social insurance, one was a housewife, and three gave no information regarding employment.
The proportion of patients with higher education, i.e. university or post-high-school education, was slightly higher than expected. According to the official statistics in Norway, the proportion of people 16-60 years with higher education in our county (Hordaland) is 20.6%. In our material 15 (34.9%) had higher education. The populations may not be directly comparable, however, because of the difference in age distribution. Exact figures are not available, but the educational status in the JME population may correspond to a normal distribution when compared to the mean age.
Family history
Twelve patients (28%), nine female and three male, had a positive family history of epilepsy. Six had certain JME and six probable JME. Eight patients reported epilepsy in close relatives, i.e. three in sisters, three in mothers, one in a brother and one in the father. Four reported epilepsy in distant relatives. Nineteen had relatives with allergy, seven with asthma, eleven with rheumatoid arthritis, ten with diabetes mellitus, eight with myocardial infarct/stroke before 60 years of age, and six with other neurological diseases.
Own medical history
Febrile convulsions in infancy had occurred in four patients. Four had a history of psychiatric symptoms, i.e. anxiety, claustrophobia, depression. One had attempted suicide. Nine patients had pollen allergy, nine excema, ten other types of allergy and three had asthma. None had diabetes mellitus, systemic lupns erythematosus (SLE) or other neurological diseases.
Seizure onset
The patients reported an age at seizure onset of 15 f 2.8 years (mean f SD) corresponding to initial inclusion criteria. The age at diagnosis was 16f4.1 years. Most (n = 32) of the patients reported GTCS as their first seizure, nine MS, one AS and one a combination of MS and AS (Fig. 1 ). Ten patients reported AS after GTCS as first seizure, and two after MS as first seizure. We were of course not able to document classical absences in this study, as most of the information derives from the questionnaire.
The first seizure was often precipitated by sleep deprivation (n = 21), eight of them in combination with alcohol intake. One had the first seizure during a febrile illness. Fifteen patients reported the first seizure related to stress, ten to puberty, five to 'family crisis', and five to head trauma. 
Seizure types
Thirty-seven patients reported having one or more GTCS and 14 reported AS (one with 'automatismus', not known from medical records). Only 35 patients reported MS as a seizure type, in spite of this being an inclusion criterion. On specific request, all patients had confirmed at least once the presence of myoclonies following awakening or during the day in accordance with medical records. In Fig. 2 , therefore, all are supposed to have had MS. According to the questionnaire five patients had MS only, 24 had MS and GTCS, 13 had MS, GTCS and AS, and one had MS and AS (Fig. 2) . According to the medical records, three had MS only (7%), 29 had MS and GTCS (67%) and 11 had MS, GTCS and AS (26%).
There is some discrepancy between the medical records and seizures reported by patients in the questionnaire. Three female patients reported AS which were previously unknown to us. Three patients who had had only one GTCS answered negatively to the question 'Have you had GTCS?' One of them denied GTCS, but confirmed AS. One patient denied AS, which were thoroughly described in his medical records. Seven patients had had only one GTCS since onset.
Seizure warning signals and postictal phenomena
Concerning characterization of their seizures, 28 considered GTCS as their 'typical' seizure, eight AS and seven MS. Sixteen patients reported the GTCS to be preceded by a warning signal, either every time or occasionally. Most often this was myoclonic jerks. Some patients had scattered myoclonies for hours preceding GTCS. One patient with only MS reported a warning signal with 'a special feeling inside the head' before the start of myoclonies. One patient had several sudden falls because of myoclonies in the legs before GTCS. Examples of other warning signals were feelings of numbness, restlessness, tremor or anxiety of short duration. One patient described a feeling of pressure in the head and 'a feeling of being outside her body' before the start of myoclonies in conjunction with AS which occurred in series, lasting up to half an hour.
After GTCS, most patients experienced confusion, fatigue and postictal sleep. Many also complained about headache. Four patients had nausea, and three described anxiety, restlessness or nervousness. In addition, three described a feeling of strong depression, despair or even guilt. This was explained further as 'regretting involving other people' or 'I totally lossed control'.
Provocational factors
Sleep deprivation was the most conspicuous factor (Fig. 3) reported in 36 patients. Two patients did not answer.
Present medication and seizure situation during the last year Thirty-nine patients used AED (90.7% of all). Of these, 31 (79.5%) used VPA alone or in combination with daily doses of 450-2100 mg. VPA as monotherapy was used by 25 (450-1500 mg daily). Four used VPA in combination with one AED (two carbamazepin, two clonazepam) and two used VPA in combination with two other AED. Clonazepam monotherapy was used by three (0.5-5 mg daily), phenytoin monotherapy by three (200-350 mg daily) and carbamazepin monotherapy by two (400 and 600 mg). All patients used AED for some time, but four were presently without treatment. Six of the 43 patients had never tried VPA. In total, 35 of the 43 patients (81.4%) had no GTCS during the last year. Twentyeight patients (65.1%) had neither GTCS nor AS, and 19 patients (44.2%) were completely free of seizures during the last year.
Side effects
Of those with seizures in the last year eight had one or more GTCS, nine one or more AS, and 21 MS. The combination of seizures were as follows (Fig. 4) : MS only in nine (38% of 24 patients), GTCS only in two, AS only in one. Four had GTCS + MS, six had AS + MS and two had GTCS + MS + AS.
The following side effects were reported (Fig. 5) , regardless of the specific AED treatment. The most unpleasant side effects were reported to be weight gain, fatigue, concentration difficulties and depression. Of the 19 seizure-free patients, three had no medication. Two patients had been seizure free for more than 10 years, eight for 5-10 years, and nine for less than 5 years. Among the 39 patients with AED treatment, 16 (41.0%) were seizure free and all of them were on monotherapy, of which 13 had VPA. One patient without AED reported more than 1OMS + AS during the last year. She preferred to regulate her lifestyle with reduced working hours, etc. She answered with a score of 5 to the question about control over seizure frequency. The two patients on carbamazepin monotherapy still had MS, but no GTCS or AS. 20 
Number
Patients' impression of seizure control
The question 'Do you feel that you have control over the frequency of seizures?' had graded answers from 'Not at all' (Score: 1) to 'Very high control' (Score: 7). Two patients did not answer (Fig. 6) . The patients that felt a considerate degree of control, mentioned regulation factors such as: avoiding alcohol, stress and music videos, getting enough sleep, taking their medication regularly, reduced working hours, etc.
Duration of epilepsy had no obvious impact on these answers. Of 10 patients with l-3.5 years since diagnosis, six reported a degree of control scoring 4-7. Of 10 patients with more than 20 years since diagnosis, seven reported a degree of control scoring 4-7.
To find out whether seizure frequency had any impact on the same question, the patients were divided in two groups, according to whether they had had any seizures during the last year or not. Interestingly, patients with seizures tended to report a higher degree (Fig. 7) . The question about control over the course of a seizure was similarly designed (Fig. 8) . Of 10 patients with a feeling of control scoring 4-7, six experienced GTCS preceded by warning factors. When they got the warning, they tried to relax, eat something, breathe deeply or take diazepam. Questions concerning the quality of life
The patents were presented questions pertaining to the impact of their epilepsy on socioeconomic, familial and private aspects of life. The purpose was not a complete psychosocial mapping however, since a group of the patients previously had replied to the Washington Psychosocial Inventory (WPSI). Most questions allowed graded answers as described in Figs 6-8. In general, patients reported little impact of their epilepsy on the quality of life and only a few answers are reported below. Of the three patients that answered 'Very annoying', two had been seizure-free for the last year, and one had only MS. The six patients that answered 'Annoying', had all had at least two types of seizures during the last year. Obviously the frequency of seizures is a factor contributing to the burden of epilepsy, but not the only one.
Figures 10 and 11 were included since the questions pertain to slightly different aspects, i.e. quality vs. absence. The four patients who answered with scores of 5-7 all had at least two seizure types during the last year. The three patients who reported absence from work of greater than 4 weeks had social insurance. The patients with frequent absence from work/studies generally had at least two seizure types during the last year. The impact of the epilepsy on social activities is generally low, as shown in Fig. 12 . Questions concerning the impact of the epilepsy on family life were answered with an almost identical profile (not shown) as in Fig. 12 . As a general statement, and support to the answers concerning social activity and family life we have included the profile of answers concerning the overall situation at present (Fig. 13 ). 
DISCUSSION
An equal distribution between sexes has been claimed for JME1,3. In our population there is a marked female predominance, the reason for which is unclear. The seizure threshold in patients with idiopathic generalized epilepsy may be lower in women than men' which could explain a female predominance in JME as suggested in other studies18-2". Alternatively, we have missed the diagnosis in male patients. Another explanation is that we examined an unselected group of patients, in contrast to studies of patients with uncontrolled epilepsy4. If this assumption is correct, one might assume better prognosis for female than male JME patients. A tentative explanation for female predominance was presented in a panel discussion2' as an overrepresentation of female patients with photic sensitivity including myoclonic jerks and occasional GTCS. These patients were classified as an overlap group that did not belong in the JME classification. With our current, strict criteria, any overlap group is not plausible. The criteria were actually established to minimize possible overlap or variability due to a large variation in onset age of epilepsy". The latter publication revealed increased incidence of epilepsy in near relatives of female JME patients, than in those of male JME patients 19. Our study sugg ests that epilepsy may be more common in female than in male relatives.
Another observation in our study is that AS may start after initial MS or GTCS, which is at variance with other investigations"'.5122. The different seizure types in JME may occur in age-related sequence, and AS is reported never to precede GTCS or MS2?. Our findings corroborate that of another recent Scandinavian investigation2'. In 10 patients AS occurred after GTCS as the first seizure, and in two patients after MS as the first seizure.
Three female patients reported AS in addition to their known seizure type. Two of them described seizures in a way suggesting that the absences might be forceful myoclonies with a feeling of brief loss of consciousness. Moreover, AS in JME may be mild and go unnoticed6. Nevertheless, seizure types were clearly defined for the patients, and in few instances AS were observed clinically and during EEG registration.
The discrepancy between seizures reported in medical records and questionnaires needs further comment. Myoclonies are often overlooked by patients or physicians, and their diagnosis will often depend on specific questioning6. Even after confirmation of myoclinic jerks, some patients obviously do not consider them as seizures and consequently do not report them. Furthermore, use of a standardized questionnaire may be compatible with a semistructured interview, which 37 may be less sensitive for generalized than for partial seizures23.
Concerning the prognosis. 19 of 43 patients (44.2%) were completely seizure free during the last year, whereas 3.5 (8 1.4%) had no GTCS. This is not impressing, since reports suggest that VPA controls seizures in approximately 80%2. However, our findings closely corroborate that of a recent Swedish study .
2o Only three patients (7%) were seizure free without medication, which is consistent with the reported relapse rate of over 90% following withdrawal 1.4. 24 Reports concerning experienced control over frequency and course of seizures referred to either warning signs or knowledge of specific triggering factors. Patients with seizures during the last year tended to report a higher degree of control over seizure frequency than patients who were seizure free. We cannot exclude an artefact in the sense no seizures: no control. Control over the course of seizures was mainly related to different warning signs.
In conclusion our clinical data confirm that Norwegian patients are comparable to those of other ethnic groups with JME, supporting the homogeneity of the JME syndrome. Despite the continuous need for medication, the prognosis in other aspects is quite favourable. The GTCS are well controlled for most of the patients, and the impact of the epilepsy on their daily lives is small for the great majority. 
